An Emergency Medicine Broadsheet
·Phoenix·
Est. MMXXVI
Blue Fish Med · Today's Topic
Cutaneous Fungal Infections
Most superficial fungal infections need no emergency intervention, but wrong-site or wrong-route treatment can prolong disease and obscure its appearance. Scalp involvement requires systemic therapy; deep or disseminated infection in an immunocompromised patient changes the urgency.
Also known astinea · dermatophytosis · ringworm · superficial mycoses · cutaneous candidiasis
By the Blue Fish Med DeskOct 11, 2026 · Phoenix
0:00 / –:––AI‑generated audio
A 29-year-old landscaper notices an itchy patch on his left forearm after a week of hot, humid shifts. By Friday, the red ring has widened, its center is paler, and a second spot has appeared on his trunk. He feels well and has no fever; he turns his arm toward you to ask whether it is spreading.
— What’s your move? Read on.
Before you read
When is topical therapy not enough?
What common treatment can make the rash harder to recognize?
When to Think of It
Consider dermatophyte infection with an enlarging, scaly plaque with an active, often raised edge and central clearing; maceration or scale between toes; or an itchy groin rash sparing the scrotum. Scalp scale, broken hairs, alopecia, or posterior cervical nodes suggest tinea capitis.
Sick or Not Sick
The key call is superficial disease in a well patient versus deep, extensive, or scalp infection requiring systemic evaluation or treatment. Fever, rapid progression, severe pain, immunocompromise, or nodules/ulcers should prompt reconsideration of routine tinea.
The First Fifteen Minutes
For localized tinea corporis/cruris/pedis with a convincing pattern → terbinafine 1% cream, apply to affected skin and surrounding margin once daily for 1–2 weeks, because it inhibits fungal ergosterol synthesis. Keep the area dry; avoid applying topical steroids alone.
For scalp involvement, widespread disease, or failure of appropriate topical therapy → terbinafine 250 mg PO daily (typically 2 weeks for corporis; scalp duration depends on organism and is longer), because systemic drug reaches infected hair follicles. Check liver history and interactions; use a reference for duration and monitoring.
If uncertain, scrape the active edge for KOH microscopy; avoid empiric systemic treatment for an atypical rash when testing or follow-up is available.
Definitive Care & Disposition
Localized disease can be treated as an outpatient; advise completing the course and avoiding shared towels, footwear, or hair tools. Tinea capitis requires oral antifungal therapy and often fungal culture; griseofulvin may be preferred for some organisms. Refer for atypical, recurrent, extensive, or treatment-resistant disease, and investigate possible deep infection in an immunocompromised patient.
How This One Kills
Treating tinea with topical corticosteroid alone can suppress redness while allowing fungal spread—creating tinea incognito and delaying the correct diagnosis.
The Differential — What Else Looks Like This
Nummular eczema — uniformly inflamed, often very itchy plaques without a leading scaly edge; mistaking it for tinea leads to unnecessary antifungals.
Granuloma annulare — smooth, non-scaly annular papules; antifungal treatment will not help.
Erythema migrans — expanding lesion after possible tick exposure, usually without a raised scaly border; missing it delays Lyme disease treatment.
The Second-Day Story
Steroid use can erase the classic raised border and central clearing, leaving a poorly defined, expanding plaque with little scale. In older or immunocompromised patients, fungal disease may be extensive or nodular rather than a tidy ring; ask about steroid exposure, examine feet and nails, and use KOH or culture when the pattern is unclear.
Back to Our Patient
Back to our 29-year-old landscaper. The enlarging, itchy plaques with a scaly advancing edge and central clearing make superficial dermatophyte infection the leading diagnosis; he is well, without features of deep or systemic disease. Treat localized lesions with topical terbinafine, advise keeping the skin dry and avoiding steroid monotherapy, and arrange follow-up if lesions spread or fail to improve; outpatient care is appropriate.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a 29-year-old landscaper presenting with one week of enlarging, itchy plaques on his forearm and trunk. The first lesion began as a small red spot and has developed a scaly outer edge with central clearing; he has no fever, pain, drainage, or systemic symptoms. He is well appearing, and the lesions are annular with peripheral scale and no fluctuance or surrounding warmth. The pattern is most consistent with localized dermatophyte infection, without evidence of deep infection. I recommend topical terbinafine, skin-hygiene advice, and follow-up if it progresses or does not respond.”
Study Directive
Draw and label the three common patterns—body/groin, foot, and scalp—and identify which need systemic therapy. Review a local or trusted drug reference for oral treatment duration by site and organism; then practice distinguishing a scaly fungal border from smooth annular mimics using five clinical images.
Recognize treatment failure or rapid recurrence as a reason to reassess the diagnosis, consider resistant dermatophytes, and arrange appropriate testing and follow-up.
Dermatologic Manifestations of Herpes Simplex Virus
HSV ranges from localized recurrent lesions to rapidly progressive skin disease, corneal injury, or disseminated infection. Early recognition of severe...
Also known asHSV · oral herpes · genital herpes · herpetic whitlow · eczema herpeticum
A 7-year-old with a history of eczema sits curled against his mother, picking at the sleeve of his sweatshirt. For two days he has had a fever, and now dozens of small, painful sores have appeared across his cheeks and the skin behind his knees. His mother says the spots seem to have appeared all at once; he blinks against the examination-room light as you reach for the door.
Before You Read
Which skin pattern makes HSV an emergency in a patient with eczema?
What finding requires urgent eye assessment?
Which patients need IV rather than oral antiviral therapy?
Why It Matters
HSV ranges from localized recurrent lesions to rapidly progressive skin disease, corneal injury, or disseminated infection. Early recognition of severe disease matters because treatment delay can cost vision or life.
When to Think of It
Suspect HSV with grouped painful vesicles or shallow ulcers, often recurring at the same site. Eczema herpeticum presents with fever and widespread, similar-appearing (“punched-out”) erosions or vesicles on eczematous skin. Eyelid or eye symptoms, neonatal lesions, immunocompromise, or systemic illness raise urgency.
Sick or Not Sick
The key call is localized, uncomplicated disease versus ocular, disseminated, neonatal, or eczema-herpeticum disease. Eye involvement or a toxic/high-risk patient needs urgent specialist input and systemic therapy; do not wait for lesion testing if severe HSV is likely.
The First Fifteen Minutes
For widespread painful monomorphic lesions on eczematous skin, systemic illness, or inability to take oral therapy → acyclovir 10 mg/kg IV every 8 hours (use ideal body weight in obesity; adjust for renal function), because inhibiting viral DNA replication limits progression. Begin promptly and hydrate; consult pediatrics/dermatology as appropriate.
For a well patient with localized first-episode mucocutaneous disease → acyclovir 400 mg PO three times daily for 7–10 days, because early replication inhibition shortens the episode; adjust for renal function.
For suspected ocular HSV → urgent ophthalmology assessment; do not start topical ocular corticosteroids without ophthalmology direction.
Definitive Care & Disposition
Admit patients with eczema herpeticum and those with ocular, disseminated, neonatal, or significant immunocompromised disease; narrow to oral therapy when improving and able to take it. Obtain HSV PCR from a fresh lesion when diagnosis is uncertain, but do not delay treatment of severe disease. Provide analgesia and hydration; assess for bacterial superinfection and corneal involvement.
How This One Kills
Missing eczema herpeticum as “infected eczema” can delay antiviral treatment while lesions rapidly spread; eye involvement can result in corneal scarring and vision loss.
The Atypical Presentation
In a patient with eczema, extensive disease may look like a sudden flare with excoriations and crust rather than intact blisters; fever may be absent early, and partially treated lesions may lose their classic appearance. In older, immunocompromised, or very young patients, lesions can be atypical or disseminated. Look for painful, similarly sized erosions in different stages, ask about eye symptoms, and lower the threshold for lesion PCR and systemic treatment.
Back to Our Patient
Back to the 7-year-old with eczema and painful facial and flexural sores. Fever plus widespread, uniform erosions on eczematous skin triggers concern for eczema herpeticum; assess vision and ocular symptoms immediately, and treat as severe disease with IV acyclovir while arranging admission and specialist evaluation. If eye involvement is found, urgent ophthalmology guides ocular care; disposition is inpatient because of the rapid progression risk.
Patient Presentation to Attending
“This is a 7-year-old with atopic dermatitis presenting with two days of fever and rapidly appearing painful sores on the face and flexures. The lesions are numerous and similar in appearance; there is no reported oral or palm/sole involvement, and he is photophobic. Exam shows eczematous skin with widespread punched-out erosions; I am concerned for eczema herpeticum with possible ocular involvement. I would start IV acyclovir now, assess visual acuity and the cornea urgently with ophthalmology, and admit for treatment and monitoring.”
Study Directive
From memory, list the HSV skin presentations that require admission or urgent consultation: eczema herpeticum, ocular disease, disseminated disease, neonatal infection, and severe immunocompromise. Practice giving the IV acyclovir dose, renal-adjustment caveat, and disposition in a 30-second oral presentation.
Key Medications
Acyclovir IV: 10 mg/kg every 8 hours for severe mucocutaneous/disseminated disease; neonatal dosing is commonly 20 mg/kg every 8 hours, but requires pediatric/neonatal protocol. Renal adjustment and hydration are essential; check a dosing reference.
Acyclovir PO: 400 mg three times daily for 7–10 days for a first mucocutaneous episode; duration and dose vary by syndrome and renal function.
Avoid topical ocular steroids unless directed by ophthalmology.
High-Yield Pearls
Eczema plus painful, monomorphic erosions is a stronger HSV warning than the presence of intact vesicles.
Photophobia or periocular lesions warrant urgent eye assessment even if the patient does not volunteer eye pain.
The Mimics
Impetigo — honey-colored crust and variable lesion stages, rather than uniform punched-out erosions; mistaking eczema herpeticum for impetigo delays antivirals.
Herpes zoster — typically grouped lesions in a unilateral dermatome; confusing it with HSV can misdirect counseling and treatment expectations.
Hand-foot-and-mouth disease — oral lesions with palm/sole involvement favor enterovirus; missing severe HSV in an at-risk patient risks progression.
Board Question
A child with atopic dermatitis develops fever and widespread, uniform punched-out erosions. What is the best next step?
ATopical corticosteroid and outpatient follow-up
BOral cephalexin alone
CStart IV acyclovir and arrange admission
DWait for viral PCR before treating
Reveal answer
Correct: C
This presentation is highly concerning for eczema herpeticum, which requires prompt systemic antiviral therapy. PCR can support the diagnosis but should not delay treatment.
3 of 4
Dermatologic Manifestations of Herpes Zoster Virus
Most localized zoster is managed outside the hospital, but disease involving the eye, ear, multiple dermatomes, or an immunocompromised patient can threaten...
Also known asshingles · herpes zoster · HZ · varicella-zoster virus · VZV
A 68-year-old teacher presses a cool washcloth to her right forehead while she waits in the ED. For three days, a burning strip of skin has hurt when her glasses touch it; this morning, small blisters appeared near the eyebrow. Her right eye waters, but she says her vision seems unchanged. She looks up as you ask whether anything has changed since the rash began.
Before You Read
Which distribution makes a zoster rash time-sensitive?
When is oral antiviral therapy not sufficient?
What examination is essential when the forehead or nose is involved?
Why It Matters
Most localized zoster is managed outside the hospital, but disease involving the eye, ear, multiple dermatomes, or an immunocompromised patient can threaten vision, hearing, or life. Prompt recognition directs antiviral treatment and the right consultation.
When to Think of It
Suspect zoster with unilateral neuropathic pain or allodynia followed by grouped vesicles in a dermatomal pattern that usually respects the midline. V1 involvement (forehead, upper eyelid, or nose), ear lesions/facial palsy, multiple dermatomes, or immunocompromise signal higher risk.
Sick or Not Sick
The key call is localized dermatomal zoster in a stable patient versus ophthalmic, otic, disseminated, or immunocompromised disease. Eye symptoms or V1 rash require urgent ocular assessment; extensive disease or serious immunocompromise generally needs IV therapy and admission.
The First Fifteen Minutes
For localized uncomplicated zoster within 72 hours of rash onset—or later if new lesions are appearing or the patient is high-risk—→ valacyclovir 1 g PO three times daily for 7 days, because early viral suppression reduces new lesions and acute pain. Adjust for renal function.
For disseminated disease, severe immunocompromise, or inability to take oral medication → acyclovir 10 mg/kg IV every 8 hours, because systemic therapy is needed for severe viral replication; adjust for renal function and provide hydration.
For V1 rash, eye pain, photophobia, red eye, or visual change → urgent ophthalmology assessment and fluorescein/slit-lamp examination where available; do not use topical ocular steroids without ophthalmology direction.
Definitive Care & Disposition
Admit for disseminated or severe disease, significant immunocompromise, neurologic complications, or inability to manage safely as an outpatient. Ophthalmic zoster requires same-day ophthalmology even if vision is initially normal; otic zoster with facial weakness warrants urgent specialist assessment. Use contact precautions for disseminated disease and for susceptible patients exposed to active lesions; provide counseling on contagiousness until lesions crust.
How This One Kills
A normal-seeming eye complaint can conceal corneal or intraocular disease; delaying ophthalmology in V1 zoster can cost vision.
The Atypical Presentation
Older adults may report only burning pain or unexplained allodynia before a rash appears; immunocompromised patients may have multiple dermatomes, atypical lesions, or little pain. A late-presenting patient can still benefit from antivirals if new lesions are forming or complications are present. Examine the full dermatome, ask about eye and ear symptoms, and do not use absence of visual change to dismiss V1 involvement.
Back to Our Patient
Back to the 68-year-old teacher with burning pain and new right forehead blisters. The unilateral V1 distribution identifies ophthalmic zoster risk even though she reports unchanged vision; examine the eye and arrange urgent ophthalmology evaluation. Start oral valacyclovir promptly if she is otherwise stable and without signs of severe disease; admit and use IV therapy if eye examination shows significant involvement, disease is disseminated, or risk factors make outpatient care unsafe. Disposition hinges on the ocular assessment and reliable same-day follow-up.
Patient Presentation to Attending
“This is a 68-year-old teacher with three days of burning right forehead pain followed by new vesicles near the eyebrow. The rash is unilateral and does not cross the midline; she has tearing but denies visual change, and there are no reported ear lesions or neurologic symptoms. Exam shows grouped forehead vesicles in the V1 distribution, so I am concerned for ophthalmic zoster. I would assess visual acuity and the cornea now, start oral valacyclovir with renal adjustment, and obtain urgent same-day ophthalmology input; disposition depends on the eye findings and follow-up reliability.”
Study Directive
Draw the three trigeminal divisions and mark which zoster distributions require urgent eye evaluation. Rehearse oral versus IV antiviral triggers and identify the exam components you would document for suspected ophthalmic zoster.
Key Medications
Valacyclovir PO: 1 g three times daily for 7 days in adults; adjust for renal function.
Acyclovir IV: 10 mg/kg every 8 hours for severe/disseminated disease; adjust for renal function and ensure hydration.
Pediatric dosing is weight-based and differs by indication; verify with a pediatric reference or institutional protocol.
High-Yield Pearls
A vesicle on the nose (Hutchinson sign) increases concern for ocular involvement, but its absence does not rule it out.
Pain may precede the rash; a normal skin exam early does not exclude zoster in a characteristic dermatomal pain syndrome.
The Mimics
Herpes simplex — recurrent clustered lesions without a consistent unilateral dermatome; mislabeling zoster can miss eye or dissemination risk.
Contact dermatitis — often intensely itchy and shaped by exposure, not preceded by dermatomal neuropathic pain; confusing it with zoster delays antivirals in high-risk disease.
Impetigo — superficial crusting without dermatomal allodynia; mistaking zoster for bacterial infection misses neural involvement.
Board Question
A patient develops grouped vesicles on the forehead and upper eyelid in a unilateral distribution. Vision is currently normal. What is the best next step?
AReassure; normal vision excludes ocular involvement
BStart oral antiviral therapy and arrange urgent ophthalmology assessment
CApply topical corticosteroid and review in one week
DTreat with oral antibiotics only
Reveal answer
Correct: B
V1 zoster can threaten the eye before the patient notices visual change. Start systemic antiviral therapy and arrange urgent ophthalmic assessment.
Recognizing a unilateral dermatomal vesicular rash helps distinguish shingles from other eruptions and prompts timely antiviral treatment, especially in high-risk patients.
Simple cellulitis and abscesses are common, but necrotizing infection can progress rapidly to shock and death. The decisive early move is recognizing when...
Also known asSSTI · cellulitis · skin abscess · erysipelas · necrotizing soft tissue infection
A 52-year-old warehouse supervisor rolls up his sleeve to show a red patch on his forearm, warm against the cool air of the exam room. He says a small scrape from a metal shelf seemed trivial yesterday, but the arm now hurts far more than it looks. He has diabetes and denies fever; you are about to decide whether the redness is the whole story.
Before You Read
What finding should make you suspect a deep, rapidly progressive infection?
Which patients need immediate surgical involvement?
When does an abscess need antibiotics in addition to drainage?
Why It Matters
Simple cellulitis and abscesses are common, but necrotizing infection can progress rapidly to shock and death. The decisive early move is recognizing when apparent skin disease needs urgent source control.
When to Think of It
Cellulitis causes expanding erythema, warmth, and tenderness; an abscess is a focal, often fluctuant collection. Disproportionate pain, rapid progression, bullae, skin anesthesia, crepitus, necrosis, systemic toxicity, or shock raise concern for necrotizing infection.
Sick or Not Sick
The call that matters most is whether necrotizing infection or sepsis is plausible. If yes, involve surgery immediately and begin broad IV therapy; imaging or a reassuring laboratory score must not delay operative evaluation.
The First Fifteen Minutes
For rapidly progressive infection with pain out of proportion, bullae, necrosis, systemic toxicity, or strong concern for necrotizing infection → vancomycin 20–25 mg/kg IV loading dose (institutional protocol; dose by actual body weight and monitor) plus piperacillin-tazobactam 4.5 g IV (typically every 6 hours or per extended-infusion protocol) plus clindamycin 900 mg IV every 8 hours. This covers MRSA, gram-negatives, and anaerobes; clindamycin suppresses toxin production. Adjust for renal function and local protocol.
For a fluctuant, uncomplicated abscess → perform incision and drainage; if MRSA coverage is indicated, TMP-SMX 1–2 double-strength tablets (160/800 mg each) PO twice daily is a common adult regimen, because it covers many community MRSA strains. Consider antibiotics for systemic signs, extensive disease, impaired host defenses, or difficult sites.
For mild nonpurulent cellulitis without MRSA risk or systemic illness → cephalexin 500 mg PO four times daily, because it covers common streptococcal pathogens.
For hypotension or sepsis → give isotonic crystalloid 30 mL/kg IV for sepsis-induced hypoperfusion, reassessing frequently because fluid needs vary with comorbidity and response.
Definitive Care & Disposition
Necrotizing infection requires emergent surgical exploration/debridement, broad antimicrobials, and admission—often ICU. Drain abscesses; culture pus when severe, recurrent, or immunocompromised. Admit for sepsis, rapid progression, failed outpatient therapy, significant immunocompromise, deep infection, or unsafe follow-up. Reassess cellulitis; erythema can take time to resolve even when therapy is effective.
How This One Kills
Waiting for imaging, laboratory confirmation, or skin changes to become dramatic before calling surgery can allow necrotizing infection to spread beyond salvageable tissue.
The Atypical Presentation
Older adults, people with diabetes, and immunocompromised patients may have little fever or leukocytosis despite severe infection. Early necrotizing disease may have intact skin and no crepitus; pain, progression, and systemic physiology can lead the visible findings. Repeatedly examine the area, mark the border, and escalate based on the whole trajectory—not a single reassuring test.
Back to Our Patient
Back to the 52-year-old with diabetes and a forearm scrape. Severe pain out of proportion to the visible erythema makes necrotizing infection a must-not-miss, despite his lack of fever; assess for toxicity, bullae, anesthesia, and rapid spread while repeating the exam. Call surgery immediately and start broad IV therapy with vancomycin, piperacillin-tazobactam, and clindamycin; do not wait for imaging if suspicion remains high. Admit for urgent surgical evaluation and source control.
Patient Presentation to Attending
“This is a 52-year-old man with diabetes presenting with rapidly worsening forearm pain and redness one day after a scrape. The pain is much more severe than the visible skin change; he denies fever, but absence of fever does not reassure me in this setting. Exam shows a warm erythematous forearm with tenderness; I am reassessing for bullae, crepitus, anesthesia, and progression. I am concerned for an early necrotizing soft-tissue infection. I recommend immediate surgical consultation, broad IV antibiotics including MRSA and toxin coverage, and admission without delaying for imaging if surgical suspicion remains high.”
Study Directive
Practice a bedside description distinguishing cellulitis, abscess, and suspected necrotizing infection. From memory, name the broad empiric necrotizing-infection regimen and its coverage targets, then rehearse the immediate surgical-consult trigger in a 30-second presentation.
Key Medications
Vancomycin IV: for suspected severe MRSA/necrotizing infection, commonly 20–25 mg/kg loading dose; maintenance dosing and monitoring vary—follow institutional protocol.
Piperacillin-tazobactam IV: 4.5 g every 6 hours or extended-infusion equivalent, adjusted for renal function.
Clindamycin IV: 900 mg every 8 hours when toxin suppression is desired.
TMP-SMX PO: 1–2 DS tablets twice daily when MRSA coverage is appropriate; dosing and duration depend on patient factors.
Cephalexin PO: 500 mg four times daily for mild nonpurulent cellulitis.
Crystalloid IV: 30 mL/kg for sepsis-induced hypoperfusion; individualize with frequent reassessment. Pediatric dosing differs; use pediatric sepsis and antimicrobial protocols.
High-Yield Pearls
A drainable collection needs source control; antibiotics alone do not replace incision and drainage.
A normal early laboratory result or absent crepitus does not safely exclude necrotizing infection.
The Mimics
Deep venous thrombosis — unilateral swelling with venous risk factors and no focal skin portal; mistaking it for cellulitis delays anticoagulation assessment.
Contact dermatitis — itch and exposure-shaped rash outweigh warmth and deep tenderness; unnecessary antibiotics follow misdiagnosis.
Necrotizing infection — pain out of proportion or rapid progression distinguishes it from routine cellulitis; treating it as uncomplicated infection delays source control.
Board Question
A patient with cellulitis has rapidly worsening pain out of proportion to exam findings and new bullae. What is the most appropriate next step?
ADischarge on oral cephalexin
BObtain MRI before contacting surgery
CImmediate surgical consultation and broad IV antibiotics
DTreat with topical antibiotic ointment
Reveal answer
Correct: C
Disproportionate pain and bullae raise concern for necrotizing infection. Surgical evaluation and broad IV antibiotics are urgent; imaging must not delay source control.
Use the purulent-versus-nonpurulent distinction to guide drainage, antibiotic selection, and decisions about escalation of care.
Yesterday’s Differential
The daily puzzle — from editions past
A quick test of recall from prior editions. Commit to an answer before you check.
From yesterday's edition
A 28-year-old man presents after a syncopal episode and a scare of rapid palpitations. He is healthy, athletic, and has no structural heart disease on prior evaluation; a maternal uncle died suddenly in his thirties. What’s the diagnosis, and the first move?
Check your answer
Short QT Syndrome. Take a young patient with a persistently short QT and syncope, palpitations, arrest, or a family history of early sudden death seriously: place them on monitoring, obtain serial/resting ECGs to confirm the QT fails to prolong at slower rates, and refer urgently to cardiology/electrophysiology — definitive treatment is ICD implantation, with quinidine as the pharmacologic option.
From the October 8 edition
Today, three days ago: Phenylephrine. What’s the adult ED dose, and the contraindication you’d most regret missing?
Check your answer
Infusion: 0.1–0.5 mcg/kg/min, titrate to MAP. Push-dose: commonly 50–200 mcg IV aliquots using institution-approved premixed concentration. Severe hypertension, ventricular tachycardia.
From the October 1 edition
A patient with advanced kidney disease has a potassium of 7.1 mEq/L, QRS widening, and no P waves. Which is the best immediate intervention?
ANebulized albuterol
BIV calcium gluconate
COral potassium binder
DIV furosemide
Reveal answer
Correct · B
IV calcium stabilizes the myocardium and is the immediate priority when hyperkalemia causes ECG changes. It does not lower serum potassium, so shifting and definitive removal must follow.
Journal Watch
From the FOAMed wire
Notable posts and reviews from the last week, ranked by relevance to today’s lead and source trust.
Journal Feed covers D10 vs D50 for hypoglycemia, virus detection in infants and IBI, and TEE guided chest compressions. The post Journal Feed Weekly Wrap-Up appeared first on emDocs .
Podcast Picks
Two for the shift
Critical Care Perspectives in Emergency Medicine2026-09-01
Brain damage and death from ischemic encephalopathy is common after cardiac arrest. Animal studies and limited observational studies suggest that high oxygen exposure after ROSC may result in neuronal death. As such, it is hypothesized that limiting oxygen exposure (conservative oxygen) many attenuate reperfusion injury and improve outcomes. At present,...
Source
Critical Care Perspectives in Emergency Medicine
Published
2026-09-01
Host
Critical Care Perspectives in Emergency Medicine, Critical Care Perspectives in Emergency Medicine
Jan and Swami kick off the month with a case, while Mike and Amal share documentation pearls. Al dives back into the glymphatic system. Meanwhile, Mel and Megan target September EMA papers, and finally, Swami and...
UMEM Pearl
Matched to today’s topics
A clinical pearl from the University of Maryland EM group’s Educational Pearls, tied to today’s differential.
In skin and soft tissue infections, suspected necrotizing fasciitis demands urgent surgical evaluation and, when needed, transfer to a center with specialized soft-tissue surgery.
University of Maryland Medical Center is a referral center for patients with necrotizing fasciitis in the region, as we have a major hyperbaric chamber, and a specialized Soft Tissue Surgery team. Therefore, patients with soft tissue infection make up a group with frequent transferring to UMMC.
Critical Care Corner
Matched to today’s topics
A critical-care reference from LITFL’s Critical Care Compendium, tied to today’s differential.
In a patient with a zoster rash, disseminated VZV can extend beyond the skin to cause pneumonitis or encephalitis—raising the stakes for isolation and IV acyclovir.
Varicella Zoster VZV = an alpha herpes virus; 90% of adults have evidence of infection; spread via droplet excreted from the throat of patients with chicken pox OR via contact with vesicle fluid in chicken pox or shingles.
Pharmacology Corner
Two drugs for the shift
One antimicrobial and one other ED workhorse — selected daily, with sources and last-reviewed dates so every dose is cross-checkable.
Antimicrobial of the Day
Cefotaxime
Third-generation IV cephalosporin
Indication
Community-acquired bacterial meningitis (with vancomycin), spontaneous bacterial peritonitis, pneumonia, and neonatal sepsis — often preferred over ceftriaxone in neonates.
What’s your dose? — reveal dosing & cautions
ED Dose
1–2 g IV q6–8h. Meningitis: 2 g IV q4–6h. SBP: 2 g IV q8h. Neonatal: 50 mg/kg/dose with age/weight-based interval.
Renal Adjustment
Halve the dose when CrCl < 20 mL/min.
Contraindications
Cephalosporin hypersensitivity.
Interactions
Minimal; probenecid increases levels.
Monitoring
Renal function, CBC.
ED Pearl
Preferred over ceftriaxone in neonates and hyperbilirubinemic infants — ceftriaxone displaces bilirubin (kernicterus risk) and is contraindicated with calcium-containing IV fluids in neonates.
Nitrate venodilator/arterial vasodilator at higher dose
Indication
Acute coronary syndrome symptom relief, hypertensive pulmonary edema/SCAPE, acute heart failure with hypertension, and esophageal spasm mimic relief after dangerous causes considered.
What’s your dose? — reveal dosing & cautions
ED Dose
SL: 0.4 mg q5 min up to 3 doses if BP allows. IV infusion: start 5–10 mcg/min and titrate; SCAPE protocols may use much higher early doses per institutional protocol.
Sildenafil/vardenafil/tadalafil/riociguat cause profound hypotension; alcohol/antihypertensives additive.
Monitoring
BP, headache, response in pulmonary edema/chest pain, signs of RV infarct.
ED Pearl
Nitro is a preload/afterload tool, not just chest-pain candy — in hypertensive pulmonary edema, aggressive nitrates plus NIV can turn the patient around fast.
For educational use only. Verify dosing against the FDA label and your institution’s pharmacy resources before administering.
ECG of the Day
Rhythm
Ashman Phenomenon
A single wide RBBB-shaped beat after a long-then-short cycle in atrial fibrillation is aberrancy, not ectopy.
The Tracing
A 74-year-old woman in known atrial fibrillation is on the monitor for palpitations. The rhythm is irregularly irregular, as expected. During one stretch a relatively long R-R interval is followed by a noticeably short one, and the beat that closes that short cycle comes out wide, with a right-bundle morphology — a tall secondary R in V1. The very next beats are narrow again. There is no fully compensatory pause around the wide complex, and the initial vector of that broad QRS looks the same as the surrounding conducted beats. She is asymptomatic and hemodynamically well throughout.
Aberrantly conducted beat, usually of RBBB morphology, following a short R-R interval that was itself preceded by a relatively long R-R interval
Most often seen in atrial fibrillation, but can occur with other supraventricular arrhythmias
RBBB-form aberrancy with a normal orientation of the initial QRS vector
A short-long-short R-R sequence is especially likely to trigger it
Lack of a fully compensatory pause; irregular coupling of the aberrant complexes
Pearls
The mechanism explains the whole pattern: His-Purkinje refractoriness tracks the preceding R-R, so a long cycle lengthens the next refractory period, and a premature beat arriving into that refractoriness conducts aberrantly.
It favors RBBB morphology because the right bundle's refractory period is slightly longer than the left's — a useful tell that a wide beat is aberrant.
On its own it is asymptomatic and needs no specific treatment; recognizing it prevents an unnecessary cascade.
Pitfalls
The core trap is calling it a PVC or a run of VT and treating ventricular ectopy that isn't there.
A normal initial QRS vector (matching conducted beats) and absence of a fully compensatory pause argue for aberrancy over ventricular origin — miss these and you overcall ectopy.
Consecutive aberrant beats are possible, so a short 'wide-complex' series in AF can still be Ashman aberrancy rather than VT.
At the Bedside
Recognizing Ashman aberrancy in atrial fibrillation lets you withhold antiarrhythmics or defibrillation aimed at ventricular ectopy and instead keep managing the underlying AF — sparing the patient an unnecessary and potentially harmful intervention.
For educational use only. Verify ECG interpretation against the LITFL entry and your institution’s practice before clinical decision-making.
Case of the Day
From the lead · Cutaneous Fungal Infections
Self-Examination
Test Your Understanding
A 29-year-old has an expanding pruritic annular plaque with peripheral scale and central clearing. He is afebrile and otherwise well. What is the best initial treatment?
ATopical hydrocortisone alone
BTopical terbinafine
COral prednisone
DOral acyclovir
Reveal answer
Correct answer · B
A scaly advancing edge with central clearing supports localized dermatophyte infection, for which topical terbinafine is appropriate. Steroid monotherapy can mask and worsen the infection.
Study Pace4 topics today; Issue 89 of 94 — Dermatology (Week 49)Deadline · June 1, 2026